Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Lea Trela-Larsen"'
Publikováno v:
Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
ABSTRACTBackground The evidence base of tisagenlecleucel is uncertain.Objective To evaluate the cost-effectiveness of tisagenlecleucel. To conduct expected value of perfect information (EVPI) and partial EVPI (EVPPI) analyses.Study Design A three-sta
Externí odkaz:
https://doaj.org/article/576d7dfbb930437fa98563998b985305
Autor:
Lea Trela-Larsen, Adrian Sayers, Ashley William Blom, Jason Crispin John Webb, Michael Richard Whitehouse
Publikováno v:
Acta Orthopaedica, Vol 89, Iss 1, Pp 40-46 (2018)
Background and purpose — To further improve the success of joint replacement surgery, attention needs to be paid to variations associated with improved or worsened outcomes. We investigated the association between the type of bone cement used and t
Externí odkaz:
https://doaj.org/article/1b2c48263db049c5ac70d90fe69eb07d
Publikováno v:
Acta Orthopaedica, Vol 88, Iss 5, Pp 530-536 (2017)
Background and purpose — Psychosocial factors are important risk factors for poor outcomes in the first year after total knee replacement (TKR), however their impact on long-term outcomes is unclear. We aimed to identify preoperative psychosocial r
Externí odkaz:
https://doaj.org/article/7a90d2722edb43ec99714548d383ec72
Autor:
Laura McCullagh, Roisin Adams, Cormac Kennedy, Lesley Tilson, Michael J. Barry, Lea Trela-Larsen
Publikováno v:
Value in Health. 24:1402-1406
This study aims to estimate the theoretical excess expenditure that would be incurred by the Irish state-payer, should drugs be reimbursed at their original asking (“list”) price rather than at a price at which the drug is considered cost-effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60c78daf4ec3439c5e93330cf2acc3ee
https://doi.org/10.1016/j.jval.2021.03.012
https://doi.org/10.1016/j.jval.2021.03.012
Publikováno v:
International journal of technology assessment in health care. 38(1)
Objectives This study evaluates the cost-effectiveness of tisagenlecleucel (a CAR T-cell therapy), versus blinatumomab, for the treatment of pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) in the Iri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3de8749ee8f93abebbb20c2d473e867
https://pubmed.ncbi.nlm.nih.gov/35815435
https://pubmed.ncbi.nlm.nih.gov/35815435
Autor:
Daniel Prieto-Alhambra, Lea Trela-Larsen, Alex J. MacGregor, Laura L. Miller, J. Mark Wilkinson, Emma Clark, Ashley W Blom
Publikováno v:
HIP International. 32:371-378
Aim: To assess revision rates and postoperative mortality in patients undergoing hip arthroplasty (HA) for inflammatory arthritis compared to hip osteoarthritis (OA). Methods: The analysis was conducted among cases of HA that were recorded in the Nat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8025576262eb980a761722ce02ac0d5b
https://doi.org/10.1177/1120700021990592
https://doi.org/10.1177/1120700021990592
Autor:
Gard Kroken, Stein Atle Lie, Parham Aram, Visakan Kadirkamanathan, J. Mark Wilkinson, Christoffer Bartz-Johannessen, Adrian Sayers, Lea Trela-Larsen, Eugene V. McCloskey, Ashley W Blom, Ove Furnes
Publikováno v:
Bone & Joint Research. 9:808-820
Aims To develop and validate patient-centred algorithms that estimate individual risk of death over the first year after elective joint arthroplasty surgery for osteoarthritis. Methods A total of 763,213 hip and knee joint arthroplasty episodes recor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fe16f9834c8672a339c35ec4feea92f
https://doi.org/10.1302/2046-3758.911.bjr-2020-0343.r1
https://doi.org/10.1302/2046-3758.911.bjr-2020-0343.r1
Autor:
Cathal Walsh, E. Fogarty, Stephen Capper, Cara Usher, Roisin Adams, Aisling O'Leary, Caitriona NiChoitir, Michael J. Barry, Ellen P O'Sullivan, Lea Trela-Larsen
Publikováno v:
Annals of Public Health Reports. 5
Clinical trials are investigating several agents as potential options for pre-exposure prophylaxis and post-exposure prophylaxis to prevent infection with COVID-19. A particular focus has been high risk groups including healthcare workers. Chloroquin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f713a56242ed8815ac4c40d6d6518749
https://doi.org/10.36959/856/513
https://doi.org/10.36959/856/513
Autor:
Cathal Walsh, Lea Trela-Larsen, Roisin Adams, Conor Hickey, Norma Bargary, Michael G. Barry, David McConnell
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 4640, p 4640 (2021)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health
SARS-CoV-2 continues to widely circulate in populations globally. Underdetection is acknowledged and is problematic when attempting to capture the true prevalence. Seroprevalence studies, where blood samples from a population sample are tested for SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb67b8862c96b042095239a2880540f
Autor:
Owen Cassidy, David McConnell, Lea Trela-Larsen, Lesley Tilson, Michael J. Barry, Conor Hickey, Laura McCullagh, Joy Leahy
Publikováno v:
Value in Health
It is expected that the coronavirus disease 2019 (COVID-19) pandemic will leave large deficits in the budgets of many jurisdictions. Funding for other treatments, in particular new treatments, may become more constrained than previously expected. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efeff7343e147f008677b7c0121886e
https://pubmed.ncbi.nlm.nih.gov/33127011
https://pubmed.ncbi.nlm.nih.gov/33127011